J. Savola
发表
P. Panula,
Y. Lyubimov,
M. Engstrom,
2010,
Neuroscience.
P. Panula,
S. Wurster,
J. Savola,
2003,
Peptides.
M. Scheinin,
S. Wurster,
J. Savola,
1999,
European journal of pharmacology.
S. Wurster,
J. Savola,
M. Engstroem,
2006,
Journal of Pharmacology and Experimental Therapeutics.
J. Savola,
1986,
Naunyn-Schmiedeberg's Archives of Pharmacology.
H. Ruskoaho,
J. Savola,
N. Kärki,
1985,
European journal of pharmacology.
J. Brotchie,
P. Ravenscroft,
S. Fox,
2019,
Movement disorders : official journal of the Movement Disorder Society.
Igor D. Grachev,
Shai Fine,
Zeev Waks,
2018,
BMC Medical Informatics and Decision Making.
S. Fine,
R. Reilmann,
M. Hayden,
2019,
Digital Biomarkers.
Assessing activation of the human neuropeptide FF2 receptor with a non-radioactive GTP binding assay
A. Närvänen,
S. Wurster,
J. Savola,
2004,
Peptides.
R. Hauser,
M. Gordon,
J. Savola,
2022,
Parkinsonism & Related Disorders.
J. Näsman,
S. Wurster,
J. Savola,
1998
.
K. Åkerman,
J. Näsman,
S. Wurster,
1998
.
A. Raasmaja,
J. Savola,
H. Vikman,
1996,
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
J. Sirviö,
J. Sallinen,
A. Haapalinna,
2007,
British journal of pharmacology.
P. Panula,
S. Wurster,
J. Savola,
2003,
Journal of Pharmacology and Experimental Therapeutics.
S. Papapetropoulos,
M. Bradbury,
I. Grachev,
2018,
British journal of clinical pharmacology.
Kamel El-Darwish,
S. Wurster,
J. Savola,
2005,
Journal of Pharmacology and Experimental Therapeutics.
M. Bradbury,
M. Gordon,
E. Hellriegel,
2020,
Clinical pharmacology in drug development.
H. Ruskoaho,
J. Savola,
N. Kärki,
1983,
Naunyn-Schmiedeberg's Archives of Pharmacology.
H. Ruskoaho,
J. Savola,
N. Kärki,
1985
.
J. Savola,
M. Savola,
1996
.
J. Jankovic,
J. Jimenez-Shahed,
B. Coffey,
2021,
JAMA network open.
J. Jankovic,
J. Jimenez-Shahed,
B. Coffey,
2021,
JAMA network open.
R. Huupponen,
M. Koulu,
U. Pesonen,
1997,
European Journal of Pharmacology.
H. Ruskoaho,
J. Savola,
N. Kärki,
1986
.
H. Ruskoaho,
J. Savola,
N. Kärki,
1986,
Life sciences.
M. Hayden,
K. Kieburtz,
S. Papapetropoulos,
2020,
Journal of Huntington's disease.
J. Savola,
R Virtanen,
J M Savola,
1988,
European journal of pharmacology.
A. Tauber,
A. Hoffrén,
J. Sallinen,
2006,
Journal of medicinal chemistry.
J. Savola,
1989,
Acta veterinaria Scandinavica. Supplementum.
J. Vlak,
M. Karp,
C. Lindqvist,
1993,
Biochimica et biophysica acta.
J. Dukart,
R. Doody,
P. Fontoura,
2017,
Journal of Alzheimer's disease : JAD.
H. Lönnberg,
S. Wurster,
J. Savola,
1996
.
J. Savola,
V. Saano,
R. Virtanen,
1989,
Archives internationales de pharmacodynamie et de therapie.
J. Savola,
1986,
Acta veterinaria Scandinavica. Supplementum.
P. Mustonen,
R. Lassila,
J. Savola,
2000,
Thrombosis research.
L. Tuomisto,
A. Haapalinna,
T. Viitamaa,
1997,
Naunyn-Schmiedeberg's Archives of Pharmacology.
M. Scheinin,
J. Savola,
B. Sjöholm,
1992
.
M. Scheinin,
J. Savola,
C. Jansson,
1997,
European journal of pharmacology.
J. Savola,
R. Virtanen,
1991,
European journal of pharmacology.
H. Ruskoaho,
J. Savola,
N. Kärki,
1986,
Journal of autonomic pharmacology.
T. Baillie,
M. Bradbury,
E. Hellriegel,
2020,
Clinical and translational science.
J. Jankovic,
B. Coffey,
B. Gertz,
2020,
CNS Spectrums.
B. Isomaa,
E. Elonen,
T. Pulli,
1990,
European journal of haematology.
M. Scheinin,
J. Savola,
B. Sjöholm,
1995,
Annals of the New York Academy of Sciences.
M. Scheinin,
K. Åkerman,
J. Savola,
1994,
European journal of pharmacology.
W. Weiner,
R. Hauser,
M. Leinonen,
2012,
Neurology.
L. Tuomisto,
A. Haapalinna,
T. Viitamaa,
1997,
Naunyn-Schmiedeberg's archives of pharmacology.
The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates
J. Brotchie,
S. Fox,
T. H. Johnston,
2010,
Movement disorders : official journal of the Movement Disorder Society.
J. Brotchie,
A. Crossman,
S. Fox,
2003,
Movement disorders : official journal of the Movement Disorder Society.
J. Kukkonen,
K. Åkerman,
S. Wurster,
1997,
European Journal of Pharmacology.
M. Karp,
K. Åkerman,
J. Näsman,
1995
.
M. Scheinin,
J. Savola,
B. Sjöholm,
1995,
Biochimica et biophysica acta.
K. Åkerman,
J. Savola,
C. Jansson,
1994
.
M. Hayden,
P. Brust,
L. Rabinovich,
2020,
European Journal of Nuclear Medicine and Molecular Imaging.
J. Jankovic,
P. Tariot,
B. Leavitt,
2022,
CNS Drugs.
M. Scheinin,
J. Savola,
V. Cockcroft,
1998,
Molecular pharmacology.
J. Kukkonen,
K. Åkerman,
K E Akerman,
1998,
Molecular pharmacology.
M. Scheinin,
J. Savola,
B. Sjöholm,
1995,
Annals of the New York Academy of Sciences.
A. Raasmaja,
S. Wurster,
J. Savola,
2003,
Archives of physiology and biochemistry.
J. Savola,
J. Puurunen,
M. Savola,
1989,
Archives internationales de pharmacodynamie et de therapie.
M. Scheinin,
L. Kanerva,
A. Hoffrén,
2003,
British journal of pharmacology.
M. Scheinin,
T. Salminen,
M. Johnson,
2001,
Molecular pharmacology.
R. Reilmann,
K. Marder,
J. Corey-Bloom,
2019,
The Lancet Neurology.
S. Factor,
R. Hauser,
M. Gordon,
2022,
Frontiers in Neurology.
J. Savola,
M. Savola,
1996,
Brain research. Developmental brain research.
H. Ruskoaho,
J. Savola,
N. Kärki,
1988,
Arzneimittel-Forschung.
R. Reilmann,
S. Tabrizi,
B. Borowsky,
2023,
Brain communications.
M. Karp,
K. Åkerman,
J. Savola,
1995,
European journal of pharmacology.
J. Klempír,
R. Schubert,
F. Squitieri,
2024,
The Lancet Neurology.
P. Piccini,
J. Savola,
Gail Rynkowski,
2019,
Neurology.